PortalPublikationenS3-Leitlinie "Helicobacter pylori und gastroduodenale Ulkusk...

S3-Leitlinie "Helicobacter pylori und gastroduodenale Ulkuskrankheit" der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)

Standard

S3-Leitlinie "Helicobacter pylori und gastroduodenale Ulkuskrankheit" der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS). / Fischbach, W; Malfertheiner, P; Hoffmann, J C; Bolten, W; Bornschein, J; Götze, O; Höhne, W; Kist, M; Koletzko, S; Labenz, J; Layer, P; Miehlke, St; Morgner, A; Peitz, U; Preiss, J C; Prinz, C; Rosien, U; Schmidt, W E; Schwarzer, A; Suerbaum, S; Timmer, A; Treiber, G; Vieth, M.

in: Z GASTROENTEROL, Jahrgang 47, Nr. 1, 01.2009, S. 68-102.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Fischbach, W, Malfertheiner, P, Hoffmann, JC, Bolten, W, Bornschein, J, Götze, O, Höhne, W, Kist, M, Koletzko, S, Labenz, J, Layer, P, Miehlke, S, Morgner, A, Peitz, U, Preiss, JC, Prinz, C, Rosien, U, Schmidt, WE, Schwarzer, A, Suerbaum, S, Timmer, A, Treiber, G & Vieth, M 2009, 'S3-Leitlinie "Helicobacter pylori und gastroduodenale Ulkuskrankheit" der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)', Z GASTROENTEROL, Jg. 47, Nr. 1, S. 68-102. https://doi.org/10.1055/s-0028-1109062

APA

Fischbach, W., Malfertheiner, P., Hoffmann, J. C., Bolten, W., Bornschein, J., Götze, O., Höhne, W., Kist, M., Koletzko, S., Labenz, J., Layer, P., Miehlke, S., Morgner, A., Peitz, U., Preiss, J. C., Prinz, C., Rosien, U., Schmidt, W. E., Schwarzer, A., ... Vieth, M. (2009). S3-Leitlinie "Helicobacter pylori und gastroduodenale Ulkuskrankheit" der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS). Z GASTROENTEROL, 47(1), 68-102. https://doi.org/10.1055/s-0028-1109062

Vancouver

Fischbach W, Malfertheiner P, Hoffmann JC, Bolten W, Bornschein J, Götze O et al. S3-Leitlinie "Helicobacter pylori und gastroduodenale Ulkuskrankheit" der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS). Z GASTROENTEROL. 2009 Jan;47(1):68-102. https://doi.org/10.1055/s-0028-1109062

Bibtex

@article{e9aa55756fd341a996f8cd8a844369d5,
title = "S3-Leitlinie {"}Helicobacter pylori und gastroduodenale Ulkuskrankheit{"} der Deutschen Gesellschaft f{\"u}r Verdauungs- und Stoffwechselkrankheiten (DGVS)",
abstract = "This guideline updates a prior concensus recommendation of the German Society for Digestive and Metabolic Diseases (DGVS) from 1996. It was developed by an interdisciplinary cooperation with representatives of the German Society for Microbiology, the Society for Pediatric Gastroenterology and Nutrition (GPGE) and the German Society for Rheumatology. The guideline is methodologically based on recommendations of the Association of the Scientific Medical Societies in Germany (AWMF) for providing a systematic evidence-based consensus guideline of S 3 level and has also implemented grading criteria according to GRADE (Grading of Recommendations Assessment, Development and Evaluation). Clinical applicability of study results as well as specifics for Germany in terms of epidemiology, antibiotic resistance status, diagnostics and therapy were taken into account.",
keywords = "Adolescent, Adult, Anti-Bacterial Agents, Anti-Ulcer Agents, Child, Cross-Sectional Studies, Drug Therapy, Combination, Evidence-Based Medicine, Gastric Mucosa, Gastroscopy, Helicobacter Infections, Helicobacter pylori, Humans, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasm Staging, Peptic Ulcer, Randomized Controlled Trials as Topic, Stomach Neoplasms, Consensus Development Conference, English Abstract, Journal Article, Practice Guideline",
author = "W Fischbach and P Malfertheiner and Hoffmann, {J C} and W Bolten and J Bornschein and O G{\"o}tze and W H{\"o}hne and M Kist and S Koletzko and J Labenz and P Layer and St Miehlke and A Morgner and U Peitz and Preiss, {J C} and C Prinz and U Rosien and Schmidt, {W E} and A Schwarzer and S Suerbaum and A Timmer and G Treiber and M Vieth",
year = "2009",
month = jan,
doi = "10.1055/s-0028-1109062",
language = "Deutsch",
volume = "47",
pages = "68--102",
journal = "Z GASTROENTEROL",
issn = "0044-2771",
publisher = "Karl Demeter Verlag GmbH",
number = "1",

}

RIS

TY - JOUR

T1 - S3-Leitlinie "Helicobacter pylori und gastroduodenale Ulkuskrankheit" der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)

AU - Fischbach, W

AU - Malfertheiner, P

AU - Hoffmann, J C

AU - Bolten, W

AU - Bornschein, J

AU - Götze, O

AU - Höhne, W

AU - Kist, M

AU - Koletzko, S

AU - Labenz, J

AU - Layer, P

AU - Miehlke, St

AU - Morgner, A

AU - Peitz, U

AU - Preiss, J C

AU - Prinz, C

AU - Rosien, U

AU - Schmidt, W E

AU - Schwarzer, A

AU - Suerbaum, S

AU - Timmer, A

AU - Treiber, G

AU - Vieth, M

PY - 2009/1

Y1 - 2009/1

N2 - This guideline updates a prior concensus recommendation of the German Society for Digestive and Metabolic Diseases (DGVS) from 1996. It was developed by an interdisciplinary cooperation with representatives of the German Society for Microbiology, the Society for Pediatric Gastroenterology and Nutrition (GPGE) and the German Society for Rheumatology. The guideline is methodologically based on recommendations of the Association of the Scientific Medical Societies in Germany (AWMF) for providing a systematic evidence-based consensus guideline of S 3 level and has also implemented grading criteria according to GRADE (Grading of Recommendations Assessment, Development and Evaluation). Clinical applicability of study results as well as specifics for Germany in terms of epidemiology, antibiotic resistance status, diagnostics and therapy were taken into account.

AB - This guideline updates a prior concensus recommendation of the German Society for Digestive and Metabolic Diseases (DGVS) from 1996. It was developed by an interdisciplinary cooperation with representatives of the German Society for Microbiology, the Society for Pediatric Gastroenterology and Nutrition (GPGE) and the German Society for Rheumatology. The guideline is methodologically based on recommendations of the Association of the Scientific Medical Societies in Germany (AWMF) for providing a systematic evidence-based consensus guideline of S 3 level and has also implemented grading criteria according to GRADE (Grading of Recommendations Assessment, Development and Evaluation). Clinical applicability of study results as well as specifics for Germany in terms of epidemiology, antibiotic resistance status, diagnostics and therapy were taken into account.

KW - Adolescent

KW - Adult

KW - Anti-Bacterial Agents

KW - Anti-Ulcer Agents

KW - Child

KW - Cross-Sectional Studies

KW - Drug Therapy, Combination

KW - Evidence-Based Medicine

KW - Gastric Mucosa

KW - Gastroscopy

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Humans

KW - Lymphoma, B-Cell

KW - Lymphoma, B-Cell, Marginal Zone

KW - Neoplasm Staging

KW - Peptic Ulcer

KW - Randomized Controlled Trials as Topic

KW - Stomach Neoplasms

KW - Consensus Development Conference

KW - English Abstract

KW - Journal Article

KW - Practice Guideline

U2 - 10.1055/s-0028-1109062

DO - 10.1055/s-0028-1109062

M3 - SCORING: Zeitschriftenaufsatz

C2 - 19156594

VL - 47

SP - 68

EP - 102

JO - Z GASTROENTEROL

JF - Z GASTROENTEROL

SN - 0044-2771

IS - 1

ER -